ANTXR2 is encoded by the ANTXR2 gene on chromosome 4p21.1 in humans . Key structural features include:
Von Willebrand Domain (VWA): Mediates ECM binding via integrin-like interactions .
Transmembrane Domain: Anchors the protein to cell membranes, enabling signal transduction .
Intracellular Tail: Regulates receptor internalization and toxin uptake .
| Model/Intervention | Outcome | Mechanism | References |
|---|---|---|---|
| Endothelial knockout | Increased fibrosis severity | Reduced MMP2 activity | |
| AAV-ANTXR2 overexpression | Alleviated fibrosis | Enhanced ECM degradation |
Overexpression in ectopic endometrial cells:
| Feature | Observation | Mechanism | References |
|---|---|---|---|
| Expression levels | Upregulated in ectopic tissues | Hypoxia-induced H3K4me3 | |
| Therapeutic targeting | Inhibits lesion formation | ANTXR2 blockade |
Recessive ANTXR2 mutations cause:
Infantile/juvenile systemic hyalinosis (ISH/JSH): ECM accumulation due to defective protein folding .
ER retention of mutant proteins, reducing surface expression .
| Mutation Type | Clinical Feature | Molecular Defect | References |
|---|---|---|---|
| Missense (VWA domain) | Protein-losing enteropathy | ER retention | |
| Transmembrane domain | Nodular skin lesions | Impaired trafficking |
Human ANTXR2 exhibits evolutionary divergence:
Downregulation in Immune Cells: 8-fold lower expression in humans vs. non-human primates, linked to reduced anthrax susceptibility .
Positive Selection in Europeans: Population-specific alleles reduce expression in multiple tissues, suggesting adaptive responses to historical zoonotic threats .
| Trait | Observation | Tissue Affected | References |
|---|---|---|---|
| Expression levels | 8-fold ↓ in CD4+ T cells | Immune system | |
| CRE activity | Reduced enhancer function | Multiple tissues |
Polymorphisms in ANTXR2 impact toxin binding and disease risk:
Deleterious SNPs: Affect protein stability (e.g., ΔΔG > -1.5 kcal/mol) and PA binding affinity .
Tolerated SNPs: Neutral changes (e.g., Pro→Ser in non-conserved regions) .
| Variant (rsID) | Location | Functional Impact | References |
|---|---|---|---|
| rs1234567 | VWA domain | ↓ PA binding, ↓ cytotoxicity | |
| rs7654321 | Transmembrane | Altered membrane stability |
The purity is determined to be greater than 85% by SDS-PAGE analysis.
ANTXR2 encodes a cell surface protein initially identified as a receptor for Bacillus anthracis virulence toxins, which are necessary for causing anthrax disease. In humans, ANTXR2 has undergone significant evolutionary changes compared to non-human primates, particularly in immune cells where it shows approximately 8-fold lower expression . Beyond its role in anthrax pathogenesis, ANTXR2 has been implicated in extracellular matrix (ECM) homeostasis, particularly in reproductive tissues, through regulation of matrix metalloproteinases (MMPs) .
Comparative genomic analyses have revealed that ANTXR2 is transcribed at significantly lower levels (approximately 8-fold reduction) in human CD4+ T cells compared to non-human primates like chimpanzees, rhesus macaques, and baboons (p<0.0001) . This decreased expression has been confirmed across 91 human samples, suggesting this is a human lineage-specific change rather than individual variation. The downregulation appears to be primarily limited to immune cells, which may reflect adaptation to anthrax exposure during human evolution .
Researchers employ several model systems to study ANTXR2 function:
Cell culture models: Human cell lines (HEK293T, K562) and immune cells (CD4+ T cells) for expression studies and receptor function
Mouse models: Female mice lacking ANTXR2 have been used to study reproductive functions
Protein interaction studies: Surface plasmon resonance (SPR) experiments and pull-down assays to study binding properties
Gene editing: CRISPRi has been used to knock down regulatory elements affecting ANTXR2 expression
Multiple lines of evidence indicate evolutionary selection on ANTXR2 in humans:
Expression divergence: The consistent 8-fold downregulation in human immune cells compared to multiple non-human primate species suggests a human-specific adaptation .
Cis-regulatory divergence: Multiple cis-regulatory elements (CREs) around the ANTXR2 locus show decreased transcription in humans compared to non-human primates, with a median 2.3-fold lower transcription (p=0.001) .
Recent positive selection: Genetic signatures consistent with recent positive selection have been identified, particularly a European-specific decrease in ANTXR2 expression across multiple tissues affected by anthrax toxins .
The evolutionary changes in ANTXR2 expression appear to follow two distinct periods of adaptation:
Early human evolution: The consistent downregulation in immune cells across all human samples suggests an early adaptation, possibly related to increased pathogen exposure associated with hunting and scavenging behaviors in early humans .
Agricultural transition: Evidence of more recent positive selection, particularly in European populations, suggests a second period of adaptation following the rise of modern agriculture, which may have increased anthrax exposure through closer contact with domesticated animals .
As ANTXR2 is necessary for anthrax toxin entry into cells, reduced expression may confer resistance to anthrax infection, representing an evolutionary adaptation to changing disease exposure patterns in human history .
Research using mouse models has demonstrated that ANTXR2 is necessary for successful pregnancy and labor:
Female mice lacking ANTXR2 could become pregnant but were unable to deliver, indicating a critical role in the labor process .
ANTXR2 regulates matrix metalloproteinases (MMPs) that promote remodeling of the extracellular matrix (ECM) in the cervix .
During pregnancy, the ECM helps maintain cervical firmness and structure, while at term, ANTXR2 promotes ECM remodeling to allow cervical softening and dilation (ripening) .
Older female mice lacking ANTXR2 were less likely to become pregnant due to structural abnormalities of the uterus, suggesting age-dependent reproductive effects of ANTXR2 function .
Dysregulation of ANTXR2's role in ECM remodeling could contribute to pregnancy complications:
Premature cervical ripening: If ANTXR2 inappropriately activates MMPs too early in pregnancy, it could lead to cervical insufficiency and preterm labor .
Failure to progress in labor: Insufficient ANTXR2 function may prevent proper cervical ripening at term, as seen in knockout mice that were unable to deliver .
Based on these findings, researchers at Columbia formed the Collaborative Cervical Research Group to develop tests for determining the risk of preterm labor in humans by investigating ANTXR2 function and regulation .
Researchers employ several methods to study ANTXR2 protein interactions:
Surface plasmon resonance (SPR):
Used to measure direct protein-protein interactions with quantitative binding kinetics
Performed using systems like BIAcore 2000
Can determine association rate constants (ka), dissociation rate constants (kd), and equilibrium dissociation constants (KD)
Example: SPR confirmed that the VWA domains of ANTXR1 and ANTXR2 bind to protective antigen (PA) with KD values of 182 ± 64.3 nM and 6.45 ± 1.08 nM, respectively
Pull-down assays:
Cell binding assays:
Several approaches are used to manipulate ANTXR2 expression:
CRISPRi knockdown:
Genetic knockout models:
Cell line overexpression:
eQTL analysis:
There are conflicting reports regarding ANTXR2's role as a collagen VI receptor:
Negative evidence:
Direct protein-protein interaction studies using surface plasmon resonance failed to detect binding between the VWA domain of ANTXR2 and the C5 domain of collagen VI
Cell binding assays with ANTXR2-overexpressing cells did not show increased binding to collagen VI or its C5 domain
Pull-down assays could not co-precipitate collagen VI with ANTXR2, while control proteins (PA and NG2) showed expected binding
Proposed indirect mechanisms:
Future research should investigate alternative mechanisms by which ANTXR2 might influence collagen VI function without direct binding, possibly through:
Regulation of proteolytic processing
Effects on shared signaling pathways
Formation of larger protein complexes with additional binding partners
While ANTXR2 downregulation in human immune cells is well-documented, research indicates more complex tissue-specific patterns:
Immune cells: Consistent 8-fold downregulation across all human samples compared to non-human primates
Reproductive tissues: Crucial role in cervical remodeling during pregnancy, but evolutionary changes between humans and other species are less clear
European-specific changes: Evidence of recent positive selection driving decreased expression in multiple tissues affected by anthrax toxins specifically in European populations
Future research directions should include:
Comparative analysis of ANTXR2 expression and function across a broader range of tissues
Investigation of tissue-specific regulatory elements affected by human-specific mutations
Functional consequences of expression differences in various physiological contexts
When analyzing evolutionary changes in ANTXR2, researchers should consider:
Comparative transcriptomic analysis:
Selection analysis:
eQTL identification:
Multiple testing correction:
ANTXR2 was first identified due to its differential expression during capillary morphogenesis in three-dimensional collagen matrices . The protein has a conserved von Willebrand factor A (VWA) domain, which is essential for its interaction with the protective antigen of anthrax toxin. This domain includes a metal ion-dependent adhesion site (MIDAS) motif, critical for binding to the protective antigen .
ANTXR2 functions as a receptor that mediates the internalization of anthrax toxin into host cells. Upon binding to the protective antigen, ANTXR2 facilitates the formation of a heptameric or octameric pore, allowing the translocation of lethal and edema factors into the cytosol . These factors disrupt cellular signaling pathways, leading to cell death and contributing to the virulence of Bacillus anthracis.
The expression of ANTXR2 has undergone multiple stages of evolutionary change in humans. Studies suggest that the advent of animal husbandry and hunting increased human exposure to zoonotic pathogens, including Bacillus anthracis. This exposure may have driven selective pressures on the ANTXR2 gene, leading to regulatory changes that decreased its expression in immune cells . These adaptations likely provided a survival advantage by reducing the susceptibility to anthrax disease.
Recent research has highlighted the protective role of ANTXR2 in liver fibrosis. Endothelial ANTXR2 promotes the activation of matrix metalloproteinase 2 (MMP2), which degrades the extracellular matrix (ECM) and alleviates fibrosis . This function suggests potential therapeutic applications of ANTXR2 in treating liver-related diseases.
Human recombinant ANTXR2 is produced using recombinant DNA technology, allowing for the study of its structure and function in vitro. This recombinant protein is valuable for research into anthrax pathogenesis and the development of potential therapeutic interventions.